М. В. Шестакова

2 ta ish

Russian Society of Cardiology

1. Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement

   С. Н. Терещенко, М. В. Шестакова, Ф. Т. Агеев +7

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.282517

2. Arterial hypertension in adults. Clinical guidelines 2020

   Zhanna Kobalava, А. О. Конради, С. В. Недогода +34

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.715464